MedTrace Logo

A Gender Transformative Implementation Strategy With Providers to Improve HIV Outcomes in Uganda

NCT05178979 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 382

Last updated 2025-04-25

Study results available
· View outcomes & findings →

Summary

Gender norms embedded in the health-system and broader community shape patient-provider relationships in ways that may undermine the provision of antiretroviral treatment (ART) counseling for men and women in Uganda. This study seeks to develop and evaluate the acceptability, feasibility, and preliminary efficacy of an innovative gender transformative implementation strategy to improve HIV provider capacity for equitable HIV care and ART adherence counseling.

Conditions

Interventions

BEHAVIORAL

Training for HIV care providers (effect on provider outcomes)

This training program integrates evidence-based strategies to reduce provider bias, adapted to address gender bias in the context of HIV care in Uganda. The content aims to increase providers' knowledge, motivation, skills, and empathy to equitably deliver Ugandan Ministry of Health ART program guidelines to male and female patients (e.g., increasing awareness of HIV gender disparities, increasing empathy/skills to counsel men and women's gendered barriers to care, promoting shared decision-making). The intervention is delivered in a series of group training sessions with HIV providers.

Sponsors & Collaborators

  • Makerere University

    collaborator OTHER

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • The University of Texas at San Antonio

    lead OTHER

Principal Investigators

  • Katelyn M Sileo, PhD, MPH · University of Texas at San Antonio

  • Rhoda K. Wanyenze, MBChB, MPH, PhD · Makerere School of Pubic Health

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-31
Primary Completion
2024-01-31
Completion
2024-01-31

Countries

  • Uganda

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05178979 on ClinicalTrials.gov